Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966667 · ClinicalTrials.gov registry record
Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
A clinical trial of Colorectal Cancer, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 222
- Enrollment target
- 14
- Study locations
NCT00966667: Completed study of Colorectal Cancer, sponsored by Rutgers, The State University of New Jersey.
NCT00966667 is a study of Colorectal Cancer that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 222 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (86% lower). The trial reports 14 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00966667, a study of Colorectal Cancer, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 222 participants
- Enrollment target
- 14
- Study locations
Study Summary
RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet. PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.
Conditions Studied
Study Locations (14)
New Jersey
- Cooper Hospital/University Medical Center - Camden
- JFK Medical Center in Edison - Edison
- Centrastate Healthcare System - Freehold
- Robert Wood Johnson University Hospital at Hamilton - Hamilton
- Mountainside Hospital - Montclair
- Morristown Medical Center - Morristown
- Jersey Shore University Medical Center - Neptune City
- Rutgers Cancer Institute of New Jersey - New Brunswick
- Saint Peters University Hospital - New Brunswick
- University Medical Center at Princeton - Princeton
- Robert Wood Johnson University Hospital Somerset - Somerville
- Overlook Medical Center - Summit
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2009-11 |
| Est. Completion | 2019-08-07 |
What the finished NCT00966667 record still lists
NCT00966667 is an observational study that tracks outcomes without assigning an intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00966667 lists 14 locations in 3 states (New Jersey, Pennsylvania, Texas).
Frequently Asked Questions
What is clinical trial NCT00966667 about?
NCT00966667 is a clinical study titled "Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer". RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet. PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment...
What is the current status of trial NCT00966667?
This trial is currently completed. The enrollment target is 222 participants. The study started on 2009-11. Estimated completion is 2019-08-07.
What conditions does trial NCT00966667 study?
This clinical trial studies the following conditions: Colorectal Cancer.
Who is sponsoring clinical trial NCT00966667?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00966667 being conducted?
This trial has 14 study locations across New Jersey, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00966667's enrollment target sits among peer trials
222 138th of 381 higher than 244 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia